BTC 
ETH 
BNB 
XRP 
SOL 
TRX Hims & Hers signs deal with Eli Lilly to sell obesity drugs
Investor's Business Daily reported that Hims & Hers Health signed a deal with Eli Lilly on Friday to sell the company's obesity drugs. The report says the agreement further entrenches Hims & Hers in the GLP-1 space and describes the deal as 'Surprising And Inevitable.'
Why “Unverified”
- Reported by Investor's Business Daily alone, with no second source or primary confirmation yet
1 independent source group across 1 post · evidence score 52/100. How labels work
What the sources claim
-
Hims & Hers Health signed a deal with Eli Lilly to sell Lilly's obesity drugs.
“Hims & Hers Health inked a deal with Eli Lilly on Friday to sell the company's obesity drugs”
Investor's Business Daily -
The deal further entrenches Hims & Hers in the GLP-1 space.
“further entrenching itself in the GLP-1 space”
Investor's Business Daily
Sources
More in Stocks & Indices
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-11-06 14:20 UTC. Labels are computed from the sources, not by the model.